Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review
- 30 April 2007
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 43 (6) , 993-1001
- https://doi.org/10.1016/j.ejca.2007.01.010
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Changing patterns in diagnosis and treatment of ductal carcinoma in situ of the breastEuropean Journal of Surgical Oncology, 2005
- American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast CancerJournal of Clinical Oncology, 2005
- Optimal management of ductal carcinoma in situ of the breastSurgical Oncology, 2003
- Comparison of morbidity between axillary lymph node dissection and sentinel node biopsyEuropean Journal of Surgical Oncology, 2003
- Towards optimal management of ductal carcinoma in situ of the breastEuropean Journal of Surgical Oncology, 2003
- Diagnostic accuracy of stereotactic large‐core needle biopsy for nonpalpable breast disease: Results of a multicenter prospective study with 95% surgical confirmationInternational Journal of Cancer, 2002
- Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistryJournal of Clinical Pathology, 2001
- The Sentinel Node in Breast Cancer — A Multicenter Validation StudyNew England Journal of Medicine, 1998
- Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodesThe Lancet, 1997
- Lymphatic Mapping and Sentinel Lymphadenectomy for Breast CancerAnnals of Surgery, 1994